Canada Markets open in 52 mins

TransEnterix, Inc. (TRXC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.3623+0.0159 (+4.59%)
At close: 4:00PM EDT

0.3515 -0.01 (-2.98%)
Before hours: 8:36AM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close0.3464
Open0.4050
Bid0.3500 x 800
Ask0.4200 x 1300
Day's Range0.3522 - 0.4280
52 Week Range0.2800 - 8.4500
Volume10,967,137
Avg. Volume5,901,900
Market Cap36.185M
Beta (5Y Monthly)2.44
PE Ratio (TTM)N/A
EPS (TTM)-4.8030
Earnings DateAug. 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
  • TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities
    Business Wire

    TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Hackensack Meridian Health Pascack Valley Medical Center, a hospital in New Jersey, successfully completed its first surgical procedures using the Intelligent Surgical UnitTM (ISU™). The technology previously received FDA clearance, and currently enables machine vision capabilities on the SenhanceⓇ Surgical System. The patients were treated by Dr. Amit Trivedi, Chair of Surgery at Hackensack Meridian Health Pascack Valley Medical Center, and his team in multiple general surgery procedures.

  • TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System
    Business Wire

    TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it established the first training center for the Senhance® Surgical System in the Asia-Pacific region in Japan at the Saitama Medical University International Medical Center in the Greater Tokyo Area.

  • TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference
    Business Wire

    TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference

    TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the H. C. Wainwright 22nd Annual Global Investment Conference. The presentation is scheduled to take place virtually at 3:00 PM Eastern, Tuesday, September 15, 2020.